Emilie Kahn

FDA investigator

Appears on 15 documents from 2016 to 2019, most often at sites in Michigan. Most often cites responsibilities of quality control unit (21 CFR 211.22).

15
Documents on file
5.1
Observations per 483
2016
First seen
2019
Most recent

What they cite most

From 77 observations

Activity by year

2016: 3, 2017: 5, 2018: 4, 2019: 3

Where

Michigan 5 · Indiana 4 · Illinois 2 · Germany 1 · Iowa 1 · Minnesota 1

Is Emilie Kahn coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 Grato Holdings, Inc.Dec 6, 2019 · Woodbine, Iowa
483 Dynalabs LLCSep 26, 2019 · Saint Louis, Missouri
483 Sage Products LLCJun 7, 2019 · Cary, Illinois
483 IntegraDose Compounding Services LLCSep 19, 2018 · Minneapolis, Minnesota
483 Baxter Oncology GmbHJun 14, 2018 · Halle/Westfalen, Germany
483 Lannett Company, Inc.Feb 2, 2018 · Seymour, Indiana
483 Techni Med, Inc. dba The CompounderJan 26, 2018 · Aurora, Illinois

About this profile

What does Emilie Kahn inspect?

Emilie Kahn appears on 15 documents on file covering 15 sites, most often in Michigan.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Emilie Kahn is dated Dec 6, 2019.